Literature DB >> 10906876

Tumor volume change as a predictor of chemotherapeutic response in osteosarcoma.

K H Shin1, S H Moon, J S Suh, W I Yang.   

Abstract

The change in osteosarcoma tumor volume after preoperative adjuvant chemotherapy and its relationship to the histopathologic response was investigated using various reproducible volumetric methods. Tumor volume was measured before and after chemotherapy in 41 patients with osteosarcoma using an ellipsoid formula in plain radiography and magnetic resonance imaging and three-dimensional magnetic resonance imaging measurement. Based on intraobserver and interobserver variability for the volumetric measurements of each method, three-dimensional magnetic resonance imaging measurement was the most reproducible. In three-dimensional magnetic resonance measurements, the correlation of the histopathologic response with absolute and relative total tumor volume changes and extraosseous volume change were significant. The good responder group showed a greater reduction in tumor volume after chemotherapy, although there was no significant difference in pretreatment tumor volume between the good and poor responder groups. The group with a decreased or stable tumor volume represented a good histopathologic response with a sensitivity of 85%, specificity of 76%, and positive predictive value of 88%. The change in tumor volume of osteosarcoma measured by three-dimensional magnetic resonance imaging could predict histopathologic response after three cycles of neoadjuvant chemotherapy.

Entities:  

Mesh:

Year:  2000        PMID: 10906876     DOI: 10.1097/00003086-200007000-00027

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  18 in total

1.  Local recurrence has only a small effect on survival in high-risk extremity osteosarcoma.

Authors:  Chang-Bae Kong; Won Seok Song; Wan Hyeong Cho; Jung Moon Oh; Dae-Geun Jeon
Journal:  Clin Orthop Relat Res       Date:  2011-10-19       Impact factor: 4.176

2.  Role of MRI in osteosarcoma for evaluation and prediction of chemotherapy response: correlation with histological necrosis.

Authors:  Jyoti Bajpai; Shivanand Gamnagatti; Rakesh Kumar; Vishnubhatla Sreenivas; Mehar Chand Sharma; Shah Alam Khan; Shishir Rastogi; Arun Malhotra; Rajni Safaya; Sameer Bakhshi
Journal:  Pediatr Radiol       Date:  2010-10-27

3.  MFH of bone and osteosarcoma show similar survival and chemosensitivity.

Authors:  Dae-Geun Jeon; Won Seok Song; Chang-Bae Kong; Jung Ryul Kim; Soo-Yong Lee
Journal:  Clin Orthop Relat Res       Date:  2010-06-18       Impact factor: 4.176

4.  Impact of close surgical margin on local recurrence and survival in osteosarcoma.

Authors:  Xin Li; Vincent M Moretti; Adedayo O Ashana; Richard D Lackman
Journal:  Int Orthop       Date:  2011-03-15       Impact factor: 3.075

5.  Tumor volume change after chemotheraphy as a predictive factor of disease free survival for osteosarcoma.

Authors:  Seong-Hwan Moon; Kyoo-Ho Shin; Jin-Suck Suh; Woo-Ick Yang; Jae-Keong Noh; Soo-Bong Hahn
Journal:  Yonsei Med J       Date:  2005-02-28       Impact factor: 2.759

6.  Proximal tumor location and fluid-fluid levels on MRI predict resistance to chemotherapy in stage IIB osteosarcoma.

Authors:  Dae-Geun Jeon; Won Seok Song; Wan Hyeong Cho; Chang-Bae Kong; Sang Hyun Cho
Journal:  Clin Orthop Relat Res       Date:  2014-02-27       Impact factor: 4.176

7.  Telangiectatic osteosarcoma: a review of 87 cases.

Authors:  Andrea Angelini; Andreas F Mavrogenis; Giulia Trovarelli; Stefano Ferrari; Piero Picci; Pietro Ruggieri
Journal:  J Cancer Res Clin Oncol       Date:  2016-07-28       Impact factor: 4.553

8.  Gene therapy to enhance allograft incorporation after host tissue irradiation.

Authors:  Brandon G Santoni; A Simon Turner; Donna L Wheeler; Richard W Nicholas; Tom J Anchordoquy; Nicole Ehrhart
Journal:  Clin Orthop Relat Res       Date:  2008-05-28       Impact factor: 4.176

9.  Effects of neoadjuvant chemotherapy on image-directed planning of surgical resection for distal femoral osteosarcoma.

Authors:  Kevin B Jones; Peter C Ferguson; Brian Lam; David J Biau; Sevan Hopyan; Benjamin Deheshi; Anthony M Griffin; Lawrence M White; Jay S Wunder
Journal:  J Bone Joint Surg Am       Date:  2012-08-01       Impact factor: 5.284

10.  Do malignant bone tumors of the foot have a different biological behavior than sarcomas at other skeletal sites?

Authors:  M Brotzmann; F Hefti; D Baumhoer; A H Krieg
Journal:  Sarcoma       Date:  2013-03-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.